Royce & Associates LP Artivion, Inc. Transaction History
Royce & Associates LP
- $9.25 Billion
- Q2 2025
A detailed history of Royce & Associates LP transactions in Artivion, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 716,680 shares of AORT stock, worth $30.9 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
716,680
Previous 687,420
4.26%
Holding current value
$30.9 Million
Previous $16.9 Million
31.91%
% of portfolio
0.24%
Previous 0.19%
Shares
32 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.1MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$286 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$128 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$121 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$120 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$100 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.74B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...